Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study
Cancer · 2026
DOI: 10.1002/cncr.70283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Bruce Montgomery und 18 weiteren Autor:innen. Beteiligte Einrichtung: VA Puget Sound Health Care System, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Genetic Testing, Veterans. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, US Department of Veterans Affairs, Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Background
Germline pathogenic variants can inform targeted therapy for metastatic prostate cancer (mPC), and improve cancer early detection and risk reduction for family members. Guidelines recommend germline genetic testing be offered to all men with mPC, yet uptake of testing is only 10%–12%.
Methods
This prospective study enrolled veterans participating in the VA Million Veteran Program (MVP) with a diagnosis of mPC. Veterans were contacted by mail with option to opt‐out of future contact. Eligible veterans who did not opt‐out were mailed study information and received a follow‐up phone call to establish interest in germline testing. Participants provided verbal consent and were mailed a saliva collection kit for a CLIA‐level multigene cancer predisposition gene panel test. Results were disclosed to the patient and oncology provider. All steps were performed with genetic counseling support.
Results
Of 2104 eligible patients, 1952 veterans with mPC did not opt out. Of these, 681 (35%) provided consent and 459 (24%) completed testing. Of those who were approached 63% were White and 25% were Black. Fifty‐nine (13%) of those completing testing carried a germline pathogenic variant in a cancer risk gene. Of the 37 eligible for targeted therapy, 14 received targeted therapy, 18 did not yet have an indication for that therapy, and five were deceased without having received targeted therapy.
Conclusions
Participant completion of remote germline testing was facilitated at rates higher than the 10% previously reported. Remote genetic testing can augment uptake of testing in large, integrated health care systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VA Puget Sound Health Care System, Seattle, Washington, USA.
- University of Washington, Seattle, Washington, USA.
- Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.
- Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
- Corporal Michael Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Bruce Montgomery, Julie A Lynch, Stacey B Whitbourne, Martin W Schoen, Rachel Ramoni
Förderung
- NCI NIH HHS
- US Department of Veterans Affairs
- Congressionally Directed Medical Research Programs
- Prostate Cancer Foundation
- Institute for Prostate Cancer Research
Zitieren
APA
Montgomery, B., Lynch, J. A., Brown, J., Maxwell, K. N., Teerlink, C. C., Kabilovic, N., Stoll, K., Simon, J., Kogan, M., Hassan, S., Whitbourne, S. B., Muralidhar, S., Schoen, M. W., Ramoni, R., Gaziano, J. M., Sokolova, A. O., Cheng, H. H., Etzioni, R., & Pritchard, C. C. (2026). Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study. Cancer. https://doi.org/10.1002/cncr.70283
Vancouver
Montgomery B, Lynch JA, Brown J, Maxwell KN, Teerlink CC, Kabilovic N, et al. Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study. Cancer. 2026. doi:10.1002/cncr.70283
BibTeX
@article{Montgomery2026,
author = {Montgomery, Bruce and Lynch, Julie A and Brown, Jessica and Maxwell, Kara N and Teerlink, Craig C and Kabilovic, Nismeta and Stoll, Katie and Simon, Julie and Kogan, Maria and Hassan, Sajida and Whitbourne, Stacey B and Muralidhar, Sumitra and Schoen, Martin W and Ramoni, Rachel and Gaziano, J Michael and Sokolova, Alexandra O and Cheng, Heather H and Etzioni, Ruth and Pritchard, Colin C},
title = {Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70283}
}
EUVIMED